静脉溶栓联合取栓与单独取栓治疗急性缺血性卒中:SWIFT与STAR研究的汇总分析
该事后分析汇总SWIFT和STAR两项多中心前瞻性试验中291例接受机械取栓的大血管闭塞急性缺血性卒中患者,比较静脉溶栓(IVT)后取栓与单独取栓的疗效与安全性。
要点
- IVT前治疗未显著改善取栓患者的90天功能独立或死亡率。
核心结论
- 对于大血管闭塞的急性缺血性卒中患者,取栓前静脉溶栓相比单独取栓未显示出临床获益。
研究设计与样本
- 事后分析汇总SWIFT(2010-2011)和STAR(2010-2012)两项多中心前瞻性临床试验中291例接受机械取栓的患者。
- 160例(55.0%)接受IVT联合MT,131例(45.0%)接受单独MT。
- 独立核心实验室评估影像学结局。
主要发现
- 成功再灌注、90天功能独立、90天死亡率及新区域栓塞两组相似。
临床怎么用
- 对于拟行机械取栓的大血管闭塞急性缺血性卒中患者,不应常规因期望额外获益而联合静脉溶栓。
- 需个体化评估IVT的获益与风险,尤其关注血管痉挛风险。
局限性
- 为事后分析,非随机对照设计,存在选择偏倚。
- 样本量有限(291例),可能不足以检测小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Mechanical thrombectomy (MT) improves clinical outcomes in patients with acute ischemic stroke (AIS) caused by a large vessel occlusion. However, it is not known whether intravenous thrombolysis (IVT) is of added benefit in patients undergoing MT. OBJECTIVE: To examine whether treatment with IVT before MT with a stent retriever is beneficial in patients undergoing MT. DESIGN, SETTING, AND PARTICIPANTS: This post hoc analysis used data from 291 patients treated with MT included in 2 large, multicenter, prospective clinical trials that evaluated MT for AIS (Solitaire With the Intention for Thrombectomy performed from January 1, 2010, through December 31, 2011, and Solitaire Flow Restoration Thrombectomy for Acute Revascularization from January 1, 2010, through December 31, 2012). An independent core laboratory scored the radiologic outcomes in each trial. INTERVENTIONS: Patients were treated with IVT with tissue plasminogen activator followed by MT (IVT and MT group) with the use of a stent retriever or MT with a stent retriever alone (MT group). MAIN OUTCOMES AND MEASURES: Successful reperfusion, functional independence (modified Rankin Scale score of 0-2) and mortality at 90 days, symptomatic intracranial hemorrhage, emboli to new territory, and vasospasm were compared. RESULTS: Of 291 patients included in the analysis, 160 (55.0%) underwent IVT and MT (mean [SD] age, 67 [13] years; 97 female [60.6%]), and 131 (45.0%) underwent MT alone (mean [SD] age, 69 [12] years; 71 [55.7%] female). Median Alberta Stroke Program Early CT Score at baseline was lower in the IVT and MT group (8 vs 9, P = .04). There was no statistically significant difference in the duration from symptom onset to groin puncture (254 minutes for the IVT and MT group vs 262 minutes for the MT group, P = .10). The number of passes, rate of successful reperfusion, functional independence at 90 days, mortality at 90 days, and emboli to new territory were also similar among groups. Symptomatic intracranial hemorrhage (1% vs 4%) and parenchymal hemorrhages type 1 (1% vs 3%) or type 2 (1% vs 2%) did not differ significantly (P = .25). Vasospasm occurred more often in patients who received IVT and MT vs MT alone (27% vs 14%, P = .006). In multivariate analysis, no statistically significant association was observed between IVT and MT vs MT alone for any of the outcomes. CONCLUSIONS AND RELEVANCE: The results indicate that treatment of patients experiencing AIS due to a large vessel occlusion with IVT before MT does not appear to provide a clinical benefit over MT alone. A randomized clinical trial seems warranted. TRIAL REGISTRATION: clinicaltrials.gov Identifiers: NCT01054560 and NCT01327989.
引用
- Coutinho JM, Liebeskind DS, Slater LA, et al. Combined Intravenous Thrombolysis and Thrombectomy vs Thrombectomy Alone for Acute Ischemic Stroke: A Pooled Analysis of the SWIFT and STAR Studies. JAMA Neurol. 2017. PMID: 28097310. doi:10.1001/jamaneurol.2016.5374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。